Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
The Journal of Urology
|
December 2, 2024
Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes
Mohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, et al.
Urology
|
November 17, 2019
Comparison of Open and Robot Assisted Radical Nephrectomy With Level I and II Inferior Vena Cava Tumor Thrombus: The Mayo Clinic Experience
Kyle M Rose, Anojan K Navaratnam, Kassem S Faraj, et al.
BJU International
|
October 12, 2021
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry
Hamed Ahmadi, Seyedeh Sanam Ladi-Seyedian, Badrinath Konety, et al.
Urologic Oncology
|
November 26, 2022
Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
Muhannad Alsyouf, Seyedeh-Sanam Ladi-Seyedian, Badrinath Konety, et al.
European Urology Oncology
|
March 24, 2020
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis
Ashish M Kamat, Seth P Lerner, Michael O'Donnell, et al.
The Journal of Urology
|
April 7, 2023
Reply by Authors
Mark D Tyson, David Morris, Juan Palou, et al.
European Urology
|
May 27, 2025
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis
Daniel S Roberson, Vidit Sharma, Stephen A Boorjian, et al.
European Urology
|
November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study
Mark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
The Journal of Urology
|
April 7, 2023
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
Mark D Tyson, David Morris, Juan Palou, et al.
The Journal of Urology
|
October 25, 2021
Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons
Meera R Chappidi, Heiko Yang, Maxwell V Meng, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
The Journal of Urology
|
December 2, 2024
Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes
Mohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, et al.
Urology
|
November 17, 2019
Comparison of Open and Robot Assisted Radical Nephrectomy With Level I and II Inferior Vena Cava Tumor Thrombus: The Mayo Clinic Experience
Kyle M Rose, Anojan K Navaratnam, Kassem S Faraj, et al.
BJU International
|
October 12, 2021
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry
Hamed Ahmadi, Seyedeh Sanam Ladi-Seyedian, Badrinath Konety, et al.
Urologic Oncology
|
November 26, 2022
Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
Muhannad Alsyouf, Seyedeh-Sanam Ladi-Seyedian, Badrinath Konety, et al.
European Urology Oncology
|
March 24, 2020
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis
Ashish M Kamat, Seth P Lerner, Michael O'Donnell, et al.
The Journal of Urology
|
April 7, 2023
Reply by Authors
Mark D Tyson, David Morris, Juan Palou, et al.
European Urology
|
May 27, 2025
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis
Daniel S Roberson, Vidit Sharma, Stephen A Boorjian, et al.
European Urology
|
November 7, 2016
Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study
Mark D Tyson, JoAnn Alvarez, Tatsuki Koyama, et al.
The Journal of Urology
|
April 7, 2023
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
Mark D Tyson, David Morris, Juan Palou, et al.
The Journal of Urology
|
October 25, 2021
Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons
Meera R Chappidi, Heiko Yang, Maxwell V Meng, et al.
Page
of 12